Followers | 12 |
Posts | 399 |
Boards Moderated | 0 |
Alias Born | 02/18/2020 |
Friday, May 28, 2021 5:11:06 PM
Posted on May 25, 2021 by Nick Corbishley
The technology looks fine, maybe its generic but it does have a purpose so they have a sales pitch and a base to start generating revenue.
The Ivermectin train is going to carry a variety of companies higher as more and more information gets to public. Also when the media and medical bureaucrats stop shutting down all the positive effects this drug will make a big comeback in the US. (Already doing well around world)
McM I agree mgmt put too many shares out there and as we saw over the recent past the stock sales are tremendous. I try to watch the canadian exchange volume/trades and they have been selling big. I have a couple buy ins now as I am looking for the turn.
Today was actually a better buy volume.
As mentioned before I think this will be a good momentum play with Ivermectin leading the publicity. I will be in this for a month or two for the gains then I will be out.
I Never fall in love with a stock/company. That was my past trading life, now I am interested in companies like this that have a hook and news to move it higher.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM